🇺🇸 FDA
Pipeline program

methoxy polyethylene glycol-epoetin beta [Mircera]

ML21736

Approved small_molecule terminated

Quick answer

methoxy polyethylene glycol-epoetin beta [Mircera] for Anemia is a Approved program (small_molecule) at Hoffmann-La Roche with 2 ClinicalTrials.gov record(s).

Program details

Company
Hoffmann-La Roche
Indication
Anemia
Phase
Approved
Modality
small_molecule
Status
terminated

Clinical trials